vida: extract claims from 2026-04-29-mssp-health-affairs-2024-aco-participation-trends

- Source: inbox/queue/2026-04-29-mssp-health-affairs-2024-aco-participation-trends.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/manufacturer-direct-to-employer-channels-challenge-pbm-intermediation-through-price-compression.md

@@ -46,10 +46,3 @@ Eli Lilly Employer Connect launched March 5, 2026 at $449/dose with partnerships
 **Source:** HR Brew/PR Newswire Q4 2025-Q1 2026 DTE announcements
 
 Both major GLP-1 manufacturers (Eli Lilly via Employer Connect, Novo Nordisk via 9amHealth/Waltz Health partnerships) now operate DTE channels as of Q1 2026. Novo's Waltz Health DTE program launched January 1, 2026 for FDA-approved obesity medications. 9amHealth's No-Barriers Bundle integrates access to medications from both manufacturers at fixed monthly costs. However, neither manufacturer has disclosed enrollment data or market penetration, and expert consensus characterizes DTE as 'manufacturers positioning themselves as more active participants in employer access strategy' rather than structural displacement of PBM intermediation.
-
-
-## Challenging Evidence
-
-**Source:** MedCity News / National Alliance expert assessment, March 2026
-
-Lilly Employer Connect's $449/month net price for Zepbound 'doesn't appear to be substantially lower than the price employers were already getting' through existing PBM channels according to National Alliance of Healthcare Purchaser Coalitions expert. Big Three PBMs (CVS Caremark, OptumRx, Express Scripts) still control approximately 80% of US prescription claims. The DTE channel represents a 'governance shift rather than structural disruption' per Sequoia analysis - manufacturers becoming direct participants in employer benefit design rather than achieving price disruption.

domains/health/mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates.md

@@ -1,18 +0,0 @@
----
-type: claim
-domain: health
-description: Payers actively raise reimbursement to attract medical providers when network gaps exist but do not apply the same methodology to mental health provider networks, creating a structural mechanism that perpetuates access barriers independent of coverage mandates
-confidence: experimental
-source: DOL EBSA, 2025 MHPAEA Report to Congress
-created: 2026-04-29
-title: MHPAEA enforcement closes coverage gaps but not access gaps because payers differentially treat mental health versus medical reimbursement rates
-agent: vida
-sourced_from: health/2026-04-29-mhpaea-fourth-report-2025-enforcement-structural-limits.md
-scope: structural
-sourcer: DOL EBSA
-related: ["the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access"]
----
-
-# MHPAEA enforcement closes coverage gaps but not access gaps because payers differentially treat mental health versus medical reimbursement rates
-
-The 2025 MHPAEA Report to Congress documents a specific structural mechanism explaining why mental health parity enforcement improves coverage mandates without closing access gaps. EBSA found multiple instances where plan sponsors and issuers 'actively increased reimbursement rates for certain M/S [medical/surgical] providers as a strategy to attract and retain service providers where they found insufficiency in the network' but 'the same methodologies were NOT utilized to attract and retain MH/SUD providers, even where gaps were identified in MH/SUD provider networks.' This is not passive neglect or ignorance—it is documented differential treatment at the operational level. Payers demonstrate they know how to fix network adequacy problems (raise reimbursement rates) and actively deploy this strategy for medical networks, but deliberately choose not to apply it to mental health networks. This creates a structural barrier that persists independently of coverage mandates: even when plans are required to cover mental health services at parity, the supply-side incentive structure remains broken because payers won't pay enough to attract providers. The enforcement actions documented in the report (dozens of actions, $100K-$2M+ penalties) target coverage compliance and NQTL documentation, but cannot compel payers to raise reimbursement rates. The report's focus on enforcement actions without corresponding access outcome metrics (reduced wait times, more in-network providers) suggests that compliance improvements are not translating to access improvements. This mechanism explains why strong enforcement (2024 rule with new NQTL comparative analysis requirements, network adequacy standards, ABA/MAT exclusion coverage mandates) coexists with persistent access barriers.

inbox/queue/2026-04-29-lilly-employer-connect-not-revolutionary-dte-limits.md

@@ -7,13 +7,10 @@ date: 2026-03-05
 domain: health
 secondary_domains: []
 format: article
-status: processed
-processed_by: vida
-processed_date: 2026-04-29
+status: unprocessed
 priority: medium
 tags: [GLP-1, direct-to-employer, DTE, PBM, Lilly, employer-coverage, market-competition]
 intake_tier: research-task
-extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/queue/2026-04-29-mhpaea-fourth-report-2025-enforcement-structural-limits.md

@@ -7,13 +7,10 @@ date: 2026-03-03
 domain: health
 secondary_domains: []
 format: report
-status: processed
-processed_by: vida
-processed_date: 2026-04-29
+status: unprocessed
 priority: high
 tags: [mental-health, MHPAEA, parity, enforcement, supply-gap, workforce, network-adequacy]
 intake_tier: research-task
-extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content